Glenmark bags FDA approval for skin ointment

India |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2016

Singapore: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food &...Read more

Lupin gets FDA nod for generic Ortho Tri-cyclen Lo Tablets

India |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 05 Jul, 2012

Mumbai: Mumbai-based pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received approval for its Norgestimate ...Read more

Lupin inks strategic JV agreement with Yoshindo

India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Pharma Major, Lupin Limited announced today that it has entered into a strategic joint venture agreement with...Read more

Ten top Indian life science collaborations of 2012

India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

As the market for new drugs evolves, the methodologies for moving them into the market is changing and becoming more com...Read more

APAC multiple myeloma market to value $2.8 bn by 2021: Report

India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2015

Singapore: The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, an...Read more

India slashes prices of 54 essential drugs

India |  News | By BioSpectrum Bureau  | 0 Comment | 12 May, 2016

Singapore: With a view to make medicines for critical diseases more affordable, India's National Pharmaceutical Pricing ...Read more

Baxter erects global R&D center at Syngene

India |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2014

Bangalore: Baxter has constructed its R&D center at Biocon's Syngene facility. The facility, which was developed a...Read more

India's Biological E to buy French Valneva's CMO unit

India |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2013

Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-b...Read more

Lupin gets 16 FDA nods, launches 11 products front

India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

US remained an unstirred focus for Indian pharmaceutical company Lupin as it went on achieving 16 approvals from US FD...Read more

FDA approves Sun Pharma's generic Prandin

India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

Singapore: The US Food and Drug Administration (FDA) has given its finally approval to India's Sun Pharmaceutical Indust...Read more

Singapore's Fortis Surgical Hospital is now Concord Medical Services

India |  News | By BioSpectrum Bureau  | 0 Comment | 16 Oct, 2015

Singapore: Concord Medical Services, China based hospital management solution provider, has received Singapore's approva...Read more

Cipla, Alembic contest Indian drug pricing in court

India |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

Singapore: Miffed at Indian government's move to slash prices of essential medicines through the new drug pricing policy...Read more

India's AYUSH becomes popular in Asia

India |  News | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2015

Singapore: With the ancient Indian medicine systems AYUSH (Ayurveda, Yoga, Unani, Siddha and Homeopathy) gaining popular...Read more

Quintiles and Biogen Idec ink pact

India |  News | By BioSpectrum Bureau  | 0 Comment | 05 May, 2014

Singapore: Quintiles and US-based biotech company Biogen Idec have entered into a five-year strategic clinical developme...Read more

Biocon launches world's first Biosimilar 'CANMAb' in India

India |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jan, 2014

Bangalore: CANMAb has been jointly developed by Biocon in partnership with Mylan and it is said to be the world's first ...Read more

Piramal to acquire US-based Decision Resource Group

India |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

Mumbai: Piramal Healthcare, an innovation led company, has agreed to acquire Decision Resources Group (DRG) a US-based c...Read more

Cadila Healthcare eyeing US, Europe markets

India |  News | By BioSpectrum Bureau  | 0 Comment | 15 Sep, 2014

Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon sta...Read more

Indian drug dealers worried about $1.69 bn old stocks

India |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

New Delhi: Ahead of the Drug Price Control Order (DPCO) to revise drug prices that came into effect on July 29, medicine...Read more